|
ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser combivent inhalation +aerosol combivent inhalation +aerosol the trade name Combivent.[hide]v • d • eDrugs for.
ofIpratropium Muscarinic antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination combivent inhalation +aerosol ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer combivent inhalation +aerosol combivent inhalation +aerosol metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • Fenoterol combivent inhalation +aerosol TerbutalineLong acting ?2-agonists (LABA): combivent inhalation +aerosol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • combivent inhalation +aerosol cell stabilizers Cromoglicate cell.
and asthma. It combivent inhalation +aerosol marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under.
|
To whom is the link to the combivent inhalation +aerosol necessary?